- Home
- FRPH vs ORIC Comparison
FRPH vs ORIC Comparison
Compare FRPH & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FRPH | ORIC |
|---|---|---|
| Founded | 1986 | 2014 |
| Country | United States | United States |
| Employees | N/A | 104 |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.6M | 861.3M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FRPH | ORIC |
|---|---|---|
| Price | $22.76 | $8.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $19.73 |
| AVG Volume (30 Days) | 70.6K | ★ 1.2M |
| Earning Date | 04-10-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $42,846,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $127.11 | ★ N/A |
| Revenue Growth | ★ 2.57 | N/A |
| 52 Week Low | $20.53 | $5.51 |
| 52 Week High | $28.35 | $14.93 |
Technical Indicators
Market Signals| Indicator | FRPH | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 37.06 |
| Support Level | $21.84 | $7.90 |
| Resistance Level | $24.59 | $11.22 |
| Average True Range (ATR) | 0.81 | 0.44 |
| MACD | 0.17 | -0.01 |
| Stochastic Oscillator | 69.38 | 30.75 |
Price Performance
Historical ComparisonAbout FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, industrial, and office (the Development Segment), and (iv) management of mixed-use residential/retail properties owned through joint ventures.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.